| ［1］ |
Mishra S, Shelly D, Vinu Balraam KV, et al. Primary cutaneous B⁃cell lymphomas: case report of two cases［J］. Indian J Dermatol, 2017,62（6）:675. doi: 10.4103/ijd.IJD_83_17.
|
| ［2］ |
Al Dhafiri M, Sicre de Fontbrune F, Marinho E, et al. Effectiveness of lenalidomide in relapsed primary cutaneous diffuse large B⁃cell lymphoma, leg type［J］. Clin Case Rep, 2019,7（5）:964⁃967. doi: 10.1002/ccr3.2137.
|
| ［3］ |
Kodama K, Massone C, Chott A, et al. Primary cutaneous large B⁃cell lymphomas: clinicopathologic features, classification, and prognostic factors in a large series of patients［J］. Blood, 2005,106（7）:2491⁃2497. doi: 10.1182/blood⁃2005⁃03⁃1175.
|
| ［4］ |
Zanelli M, Zizzo M, Ascani S. Asymptomatic infiltrated erythematous skin patch on the breast［J］. JAMA Dermatol, 2019,155（12）:1420⁃1421. doi: 10.1001/jamadermatol.2019.3273.
|
| ［5］ |
高天文, 王雷, 廖文俊. 实用皮肤组织病理学. 2版. 北京: 人民卫生出版社, 2018.
|
| ［6］ |
Willemze R, Jaffe ES, Burg G, et al. WHO⁃EORTC classification for cutaneous lymphomas［J］. Blood, 2005,105（10）:3768⁃3785. doi: 10.1182/blood⁃2004⁃09⁃3502.
|
| ［7］ |
Zinzani PL, Quaglino P, Pimpinelli N, et al. Prognostic factors in primary cutaneous B⁃cell lymphoma: the Italian Study Group for Cutaneous Lymphomas［J］. J Clin Oncol, 2006,24（9）:1376⁃1382. doi: 10.1200/JCO.2005.03.6285.
|
| ［8］ |
Hans CP, Weisenburger DD, Greiner TC, et al. Confirmation of the molecular classification of diffuse large B⁃cell lymphoma by immunohistochemistry using a tissue microarray［J］. Blood, 2004,103（1）:275⁃282. doi: 10.1182/blood⁃2003⁃05⁃1545.
|
